Matthew Pauls
Directeur Général chez SAVARA INC.
Fortune : 2 M $ au 30/06/2024
Profil
Matthew Pauls is the founder of Spartan Biopharma Insights LLC.
He currently holds the position of Chairman & Chief Executive Officer at Savara, Inc. since 2020.
He is also an Independent Director at Soleno Therapeutics, Inc. starting in 2023.
Additionally, he serves as a Director at The Pennington School, The Boys & Girls Clubs of Philadelphia, and Amplo Biotechnology, Inc. Mr. Pauls previously worked as the President, Chief Executive Officer & IR Officer at Cortendo AB.
From 2014 to 2019, he held the position of President, Chief Executive Officer & Director at Strongbridge Biopharma Plc.
He was also the Chairman of Mast Therapeutics, Inc. from 2015 to 2017.
Mr. Pauls has experience as a Director at Aravas, Inc. and Zyla Life Sciences LLC.
He served as the Chief Commercial Officer at Insmed, Inc. from 2013 to 2014 and as the Senior VP & Head-Global Commercial Operations at Shire Pharmaceuticals, Inc. from 2007 to 2013.
Mr. Pauls obtained his undergraduate degree in 1993 and his MBA in 1996 from Central Michigan University.
He also holds a graduate degree from Michigan State University College of Law, which he received in 2000.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SAVARA, INC.
0,37% | 08/04/2024 | 508 674 ( 0,37% ) | 2 M $ | 30/06/2024 |
SOLENO THERAPEUTICS INC
0,02% | 06/06/2024 | 6 500 ( 0,02% ) | 265 200 $ | 30/06/2024 |
Postes actifs de Matthew Pauls
| Sociétés | Poste | Début |
|---|---|---|
| SAVARA INC. | Directeur Général | 11/09/2020 |
| SOLENO THERAPEUTICS, INC. | Directeur/Membre du Conseil | 15/08/2023 |
| The Pennington School | Directeur/Membre du Conseil | - |
| The Boys & Girls Clubs of Philadelphia | Directeur/Membre du Conseil | - |
Amplo Biotechnology, Inc.
 Amplo Biotechnology, Inc. BiotechnologyHealth Technology Amplo Biotechnology, Inc. operates as an American biotechnology company. The CEO of the company is Patricio Sepulveda. | Directeur/Membre du Conseil | - |
Anciens postes connus de Matthew Pauls
| Sociétés | Poste | Fin |
|---|---|---|
| STRONGBRIDGE BIOPHARMA | Directeur Général | 05/11/2019 |
Mast Therapeutics, Inc.
 Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | Président | 01/04/2017 |
| INSMED INCORPORATED | Corporate Officer/Principal | 01/08/2014 |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Corporate Officer/Principal | 01/04/2013 |
| ░░░░░░░ ░░░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░ | - |
Formation de Matthew Pauls
| Central Michigan University | Masters Business Admin |
| Michigan State University College of Law | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| INSMED INCORPORATED | Health Technology |
| SAVARA INC. | Health Technology |
| SOLENO THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 9 |
|---|---|
Cortendo AB
 Cortendo AB Miscellaneous Commercial ServicesCommercial Services Cortendo AB engages in the provision of biopharmaceutical business. Its activities include development and distribution of orphan drugs for metabolic and endocrine diseases as well as diabetes. Its products include cortisol inhibition and normocort. The company was founded on October 6, 1996 and is headquartered in Trevose, PA. | Commercial Services |
Strongbridge Biopharma Plc
 Strongbridge Biopharma Plc Pharmaceuticals: MajorHealth Technology Strongbridge Biopharma Plc operates as a commercial-stage biopharmaceutical company, which focuses on the development and commercialization of therapies for rare diseases. Its pipeline is comprised of Keveyis, Macrilen, Recorlev, and Veldoreotide. The company was founded in 1996 and is headquartered in Trevose, PA. | Health Technology |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | Health Technology |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Health Technology |
| The Boys & Girls Clubs of Philadelphia | |
Aravas, Inc.
 Aravas, Inc. Pharmaceuticals: MajorHealth Technology Aravas, Inc. develops innovative drugs for the treatment of serious and life-threatening conditions. It develops dry powder formulations for various therapeutic molecules, including antibiotics, corticosteroids, nucleic acids, and insoluble and soluble molecules. The firm’s products include AeroVanc, an inhaled dry powder form of vancomycin in a capsule-based inhaler to treat methicillin-resistant staphylococcus aureus infections in patients with cystic fibrosis or other lung-compromising conditions; and AeroCort, a high performance inhaled corticosteroid product for the treatment of asthma in children. The company was founded by Cory Berkland, Chris Marich, Robert N. Neville, Taneli Jouhikainen, Chal Lenge and George Laurence in March 2007 and is headquartered in Austin, TX. | Health Technology |
Zyla Life Sciences LLC
 Zyla Life Sciences LLC Pharmaceuticals: MajorHealth Technology Zyla Life Sciences is a commercial-stage company, which focuses on developing, manufacturing and commercializing innovative treatments for pain. It is focused on bringing non-narcotic products and abuse-discouraging formulations of opioids to patients and healthcare providers. The company plans to continue to grow revenue of its seven commercial products, which includes Sprix nasal spray, Vivlodex, Zorvolex, Tivorbex, Indocin suppositories, Indocin oral suspension and oxaydo tablets, and explore business development opportunities. Zyla Life Sciences was founded in August 2013 and is headquartered in Wayne, PA. | Health Technology |
Amplo Biotechnology, Inc.
Amplo Biotechnology, Inc. BiotechnologyHealth Technology Amplo Biotechnology, Inc. operates as an American biotechnology company. The CEO of the company is Patricio Sepulveda. | Health Technology |
| Spartan Biopharma Insights LLC |
